CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE
Delisted
CERE was delisted on the 31st of July, 2024.
210 hedge funds and large institutions have $6.67B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 82 increasing their positions, 49 reducing their positions, and 29 closing their positions.
Holders
210
Holders Change
+15
Holders Change %
+7.69%
% of All Funds
3.04%
Holding in Top 10
10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-9.09%
% of All Funds
0.14%
New
45
Increased
82
Reduced
49
Closed
29
Calls
$60M
Puts
$47.1M
Net Calls
+$12.9M
Net Calls Change
+$10.5M
Top Buyers
| 1 |
SFM
1
Soros Fund Management
New York
|
$82M |
| 2 |
UOC
2
UBS O'Connor
Chicago,
Illinois
|
$137M |
| 3 |
3
Citigroup
New York
|
$80.1M |
| 4 |
PCM
4
Pentwater Capital Management
Naples,
Florida
|
$93.8M |
| 5 |
5
Marshall Wace
London,
United Kingdom
|
$51.7M |
